
Metlip 47.5mg Tablet ER
Marketer
Zorion Drugs & Herbs Pvt. Ltd.
Salt Composition
Metoprolol Succinate (47.5mg)
Overview Metlip 47.5mg Tablet ER
Cardiol 47.5mg Extended-Release Tablets are classified as beta-adrenergic blocking agents. This medication treats elevated blood pressure (hypertension), angina pectoris (chest discomfort stemming from heart issues), and cardiac arrhythmias (irregular heartbeats). It also aids in migraine prevention and reducing the risk of future myocardial infarctions and cerebrovascular accidents (strokes). Cardiol 47.5mg ER may be administered alone or in conjunction with other therapies. Dosage and frequency are determined by your specific condition and its severity. It can be taken with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic effects may take several weeks to manifest, and long-term use is often necessary. Continued use is vital even with symptom improvement; discontinuation can exacerbate underlying conditions. Common side effects include fatigue, cephalalgia (headache), depressed mood, diarrhea, dermatological reactions (rash), bradycardia (slow heart rate), dizziness, and nausea. These are typically mild and transient. Some individuals may experience dyspnea (shortness of breath) or hypotension (low blood pressure). To minimize adverse events, your physician will likely initiate treatment with a low dose, gradually increasing it as tolerated. Report any persistent or bothersome side effects to your doctor. Prior to commencing treatment, disclose any hepatic (liver) impairment. This medication may be unsuitable for those with bradycardia, significant circulatory issues, severe congestive heart failure, or hypotension. Pregnant or lactating individuals should consult their physician before use. A physician's evaluation is essential to determine suitability. Regular blood pressure monitoring is necessary to assess treatment effectiveness. Alcohol consumption should be limited due to the potential for increased side effects.
Uses of Metlip 47.5mg Tablet ER
Managing angina pectoris (chest pain from heart issues)|Correcting cardiac arrhythmias|Reducing the risk of myocardial infarction|Treating arterial hypertension (high blood pressure)|Preventing migraine episodes
Major Benefits of Metlip 47.5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Metlip 47.5mg Extended-Release tablet whole; do not chew, crush, or divide it. While it can be taken with or without food, consistency is key – take it at the same time each day. To optimize absorption, avoid consuming Metlip 47.5mg Tablet ER with meals high in fat, including foods like olive oil, nuts (especially Brazil nuts), dark chocolate, butter, and red meat.
Common Side effects of Metlip 47.5mg Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metlip 47.5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 47.5mg extended-release Metlip tablet whole; do not crush, chew, or break it. While it can be taken with or without food, consistency is key—take it at the same time each day. Minimize consumption of high-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and meat, when taking Metlip 47.5mg Tablet ER.
How Metlip 47.5mg Tablet ER works:
Extended-release Metlip 47.5mg tablets are a cardioselective beta-adrenergic blocker, reducing heart rate and improving cardiac output.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metlip 47.5mg Extended-Release Tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metlip 47.5mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metlip 47.5mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Extended-release Metlip 47.5mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Metlip 47.5mg tablets are considered safe for patients with renal impairment. No dosage modification is necessary for Metlip 47.5mg extended-release tablets in this population.
LiverCAUTION
Patients with hepatic impairment should use Metlip 47.5mg Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Metlip 47.5mg Tablet ER :
Should you forget a Metlip 47.5mg Extended-Release Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount.
Facts to Know About Metlip 47.5mg Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |
